Interaction between OCT1 and LPIN1 polymorphisms and response to pioglitazone-metformin tablets in patients with polycystic ovary syndrome.

Author: Haixia ZENG ¹ ; Yanting HUANG ² ; Dengke LIU ¹ ; Tianqin XIE ¹ ; Zheng CHEN ¹ ; Qiulan HUANG ¹ ; Xiaojun ZHOU ³ ; Xiaoyang LAI ¹ ; Jianping LIU ¹
Author Information

1. Department of Endocrinology, Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
2. Department of Endocrinology, Xiangyang First People's Hospital, Xiangyang, Hubei 441099, China.
3. School of Public Health, Nanchang University, School of Public Health, Nanchang University, Nanchang, Jiangxi 330031, China.
Publication Type:Letter
MeSH: Female; Humans; Hypoglycemic Agents/therapeutic use*; Insulin Resistance; Metformin/therapeutic use*; Phosphatidate Phosphatase; Pioglitazone/therapeutic use*; Polycystic Ovary Syndrome/genetics*
From: Chinese Medical Journal 2023;136(14):1756-1758
CountryChina
Language:English